Biocon Limited has informed the Exchange about press release dated 17-Oct-2022 titled "Biocon Biologics Out-Licenses Two Biosimilar Assets to Yoshindo for Commercialization in Japan"
Biocon Limited has informed the Exchange about press release dated 17-Oct-2022 titled "Biocon Biologics Out-Licenses Two Biosimilar Assets to Yoshindo for Commercialization in Japan"